-
1
-
-
80053520936
-
Kinins as therapeutic agents in cardiovascular and renal diseases
-
Alhenc-Gelas, F., Bouby, N., Richer, C., Potier, L., Roussel, R., and Marre, M. (2011). Kinins as therapeutic agents in cardiovascular and renal diseases. Curr. Pharm. Des. 17, 2654-2662.
-
(2011)
Curr. Pharm. Des.
, vol.17
, pp. 2654-2662
-
-
Alhenc-Gelas, F.1
Bouby, N.2
Richer, C.3
Potier, L.4
Roussel, R.5
Marre, M.6
-
2
-
-
33750954154
-
Disruption of the kinin B1 receptor gene affects potentiating effect of captopril on BK-induced contraction in mice stomach fundus
-
Barbosa, A.M., Felipe, S.A., Pesquero, J.B., Paiva, A.C., and Shimuta, S.I. (2006). Disruption of the kinin B1 receptor gene affects potentiating effect of captopril on BK-induced contraction in mice stomach fundus. Peptides 27, 3377-3382.
-
(2006)
Peptides
, vol.27
, pp. 3377-3382
-
-
Barbosa, A.M.1
Felipe, S.A.2
Pesquero, J.B.3
Paiva, A.C.4
Shimuta, S.I.5
-
3
-
-
33947122204
-
Effects of anti-hypertensive drugs on vessel rarefaction
-
Battegay, E.J., de Miguel, L.S., Petrimpol, M., and Humar, R. (2007). Effects of anti-hypertensive drugs on vessel rarefaction. Curr. Opin. Pharmacol. 7, 151-157.
-
(2007)
Curr. Opin. Pharmacol.
, vol.7
, pp. 151-157
-
-
Battegay, E.J.1
De Miguel, L.S.2
Petrimpol, M.3
Humar, R.4
-
4
-
-
62749205749
-
Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor
-
Bélanger, S., Bovenzi, V., Côté, J., Neugebauer, W., Amblard, M., Martinez, J., Lammek, B., Savard, M., and Gobeil, F. Jr. (2009). Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor. Peptides 30, 777-787.
-
(2009)
Peptides
, vol.30
, pp. 777-787
-
-
Bélanger, S.1
Bovenzi, V.2
Côté, J.3
Neugebauer, W.4
Amblard, M.5
Martinez, J.6
Lammek, B.7
Savard, M.8
Gobeil Jr., F.9
-
5
-
-
0028979356
-
Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons
-
Borkowski, J.A., Ransom, R.W., Seabrook, G.R., Trumbauer, M., Chen, H., Hill, R.G., Strader, C.D., and Hess, J.F. (1995). Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J. Biol. Chem. 270, 13706-13710.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 13706-13710
-
-
Borkowski, J.A.1
Ransom, R.W.2
Seabrook, G.R.3
Trumbauer, M.4
Chen, H.5
Hill, R.G.6
Strader, C.D.7
Hess, J.F.8
-
6
-
-
0038399929
-
Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: Laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
-
Borlongan, C.V. and Emerich, D.F. (2003). Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: Laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport. Brain Res. Bull. 60, 297-306.
-
(2003)
Brain Res. Bull.
, vol.60
, pp. 297-306
-
-
Borlongan, C.V.1
Emerich, D.F.2
-
7
-
-
73949137639
-
Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli
-
Bovenzi, V., Savard, M., Morin, J., Cuerrier, C.M., Grandbois, M., and Gobeil, F. Jr. (2010). Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli. J. Cell. Physiol. 222, 168-176.
-
(2010)
J. Cell. Physiol.
, vol.222
, pp. 168-176
-
-
Bovenzi, V.1
Savard, M.2
Morin, J.3
Cuerrier, C.M.4
Grandbois, M.5
Gobeil Jr., F.6
-
8
-
-
0033048762
-
Bradykinin stimulates tissue plasminogen activator release in human vasculature
-
Brown, N.J., Gainer, J.V., Stein, C.M., and Vaughan, D.E. (1999). Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 33, 1431-1435.
-
(1999)
Hypertension
, vol.33
, pp. 1431-1435
-
-
Brown, N.J.1
Gainer, J.V.2
Stein, C.M.3
Vaughan, D.E.4
-
9
-
-
62749133920
-
Novel kinin B1 receptor agonists with improved pharmacological profiles
-
Côté, J., Savard, M., Bovenzi, V., Bélanger, S., Morin, J., Neugebauer, W., Larouche, A., Dubuc, C., and Gobeil, F. Jr. (2009). Novel kinin B1 receptor agonists with improved pharmacological profiles. Peptides 30, 788-795.
-
(2009)
Peptides
, vol.30
, pp. 788-795
-
-
Côté, J.1
Savard, M.2
Bovenzi, V.3
Bélanger, S.4
Morin, J.5
Neugebauer, W.6
Larouche, A.7
Dubuc, C.8
Gobeil Jr., F.9
-
10
-
-
4644337419
-
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
-
Couture, R. and Girolami, J.P. (2004). Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur. J. Pharmacol. 500, 467-485.
-
(2004)
Eur. J. Pharmacol.
, vol.500
, pp. 467-485
-
-
Couture, R.1
Girolami, J.P.2
-
11
-
-
84863007384
-
Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb
-
Cruden, N.L., Lang, N.N., Macgillivray, T.J., Uren, N.G., Fox, K.A., and Newby, D.E. (2011). Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Heart Vessels 27, 179-185.
-
(2011)
Heart Vessels
, vol.27
, pp. 179-185
-
-
Cruden, N.L.1
Lang, N.N.2
Macgillivray, T.J.3
Uren, N.G.4
Fox, K.A.5
Newby, D.E.6
-
12
-
-
78149362102
-
Secondary prevention of CAD with ACE inhibitors: A struggle between life and death of the endothelium
-
Ferrari, R., Guardigli, G., and Ceconi, C. (2010). Secondary prevention of CAD with ACE inhibitors: A struggle between life and death of the endothelium. Cardiovasc. Drugs Ther. 24, 331-339.
-
(2010)
Cardiovasc. Drugs Ther.
, vol.24
, pp. 331-339
-
-
Ferrari, R.1
Guardigli, G.2
Ceconi, C.3
-
13
-
-
0038000657
-
Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor ?
-
Fortin, J.P., Gobeil, F. Jr., Adam, A., Regoli, D., and Marceau, F. (2003). Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor ? Am. J. Physiol. Heart. Circ. Physiol. 285, H277-282.
-
(2003)
Am J. Physiol. Heart. Circ. Physiol.
, vol.285
-
-
Fortin, J.P.1
Gobeil Jr., F.2
Adam, A.3
Regoli, D.4
Marceau, F.5
-
14
-
-
0029886444
-
In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig
-
Gobeil, F., Filteau, C., Pheng, L.H., Jukic, D., Nguyen-Le, X.K., and Regoli, D. (1996). In vitro and in vivo characterization of bradykinin B2 receptors in the rabbit and the guinea pig. Can. J. Physiol. Pharmacol. 74, 137-144.
-
(1996)
Can. J. Physiol. Pharmacol.
, vol.74
, pp. 137-144
-
-
Gobeil, F.1
Filteau, C.2
Pheng, L.H.3
Jukic, D.4
Nguyen-Le, X.K.5
Regoli, D.6
-
15
-
-
0033088896
-
Kinin B1 receptor antagonists containing 〈 -methyl- l -phenylalanine: In vitro and in vivo antagonistic activities
-
Gobeil, F. Jr., Charland, S., Filteau, C., Perron, S.I., Neugebauer, W., and Regoli, D. (1999). Kinin B1 receptor antagonists containing 〈 -methyl- l -phenylalanine: In vitro and in vivo antagonistic activities. Hypertension 33, 823-829.
-
(1999)
Hypertension
, vol.33
, pp. 823-829
-
-
Gobeil Jr., F.1
Charland, S.2
Filteau, C.3
Perron, S.I.4
Neugebauer, W.5
Regoli, D.6
-
16
-
-
0036210811
-
Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: Modulation of contractile response to bradykinin
-
Gobeil, F. Jr., Halle, S., Blais, P.A., and Regoli, D. (2002). Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: Modulation of contractile response to bradykinin. Can. J. Physiol. Pharmacol. 80, 153-163.
-
(2002)
Can. J. Physiol. Pharmacol.
, vol.80
, pp. 153-163
-
-
Gobeil Jr., F.1
Halle, S.2
Blais, P.A.3
Regoli, D.4
-
17
-
-
13344287044
-
Bradykinin receptor antagonists containing N-substituted amino acids: In vitro and in vivo B2 and B1 receptor antagonist activity
-
Goodfellow, V.S., Marathe, M.V., Kuhlman, K.G., Fitzpatrick, T.D., Cuadrado, D., Hanson, W., Zuzack, J.S., Ross, S.E., Wieczorek, M., Burkard, M., et al. (1996). Bradykinin receptor antagonists containing N-substituted amino acids: In vitro and in vivo B2 and B1 receptor antagonist activity. J. Med. Chem. 39, 1472-1484.
-
(1996)
J. Med. Chem.
, vol.39
, pp. 1472-1484
-
-
Goodfellow, V.S.1
Marathe, M.V.2
Kuhlman, K.G.3
Fitzpatrick, T.D.4
Cuadrado, D.5
Hanson, W.6
Zuzack, J.S.7
Ross, S.E.8
Wieczorek, M.9
Burkard, M.10
-
18
-
-
0027067804
-
Bradykinin receptors: Pharmacological properties and biological roles
-
Hall, J.M. (1992). Bradykinin receptors: Pharmacological properties and biological roles. Pharmacol. Ther. 56, 131-190.
-
(1992)
Pharmacol. Ther.
, vol.56
, pp. 131-190
-
-
Hall, J.M.1
-
19
-
-
0038811842
-
The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease
-
Heitsch, H. (2003). The therapeutic potential of bradykinin B2 receptor agonists in the treatment of cardiovascular disease. Expert Opin. Invest. Drugs 12, 759-770.
-
(2003)
Expert Opin. Invest. Drugs
, vol.12
, pp. 759-770
-
-
Heitsch, H.1
-
20
-
-
0035109657
-
Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors
-
Hess, J.F., Hey, P.J., Chen, T.B., O'Brien, J., Omalley, S.S., Pettibone, D.J., and Chang, R.S. (2001). Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors. Biol. Chem. 382, 123-129.
-
(2001)
Biol. Chem.
, vol.382
, pp. 123-129
-
-
Hess, J.F.1
Hey, P.J.2
Chen, T.B.3
O'Brien, J.4
Omalley, S.S.5
Pettibone, D.J.6
Chang, R.S.7
-
21
-
-
0034009830
-
Inactivation of bradykinin by angiotensinconverting enzyme and by carboxypeptidase N in human plasma
-
Kuoppala, A., Lindstedt, K.A., Saarinen, J., Kovanen, P.T., and Kokkonen, J.O. (2000). Inactivation of bradykinin by angiotensinconverting enzyme and by carboxypeptidase N in human plasma. Am. J. Physiol. Heart Circ. Physiol. 278, H1069-1074.
-
(2000)
Am. J. Physiol. Heart Circ. Physiol.
, vol.278
-
-
Kuoppala, A.1
Lindstedt, K.A.2
Saarinen, J.3
Kovanen, P.T.4
Kokkonen, J.O.5
-
22
-
-
0034745988
-
Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse
-
Labont é, J., Brochu, I., Honor é, J.C., and D'Orl é ans-Juste, P. (2001). Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse. Br. J. Pharmacol. 132, 934-940.
-
(2001)
Br. J. Pharmacol.
, vol.132
, pp. 934-940
-
-
Labonté, J.1
Brochu, I.2
Honoré, J.C.3
D'Orléans-Juste, P.4
-
23
-
-
14144251086
-
International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences
-
Leeb-Lundberg, L.M., Marceau, F., M ü ller-Esterl, W., Pettibone, D.J., and Zuraw, B.L. (2005). International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27-77.
-
(2005)
Pharmacol. Rev.
, vol.57
, pp. 27-77
-
-
Leeb-Lundberg, L.M.1
Marceau, F.2
Müller-Esterl, W.3
Pettibone, D.J.4
Zuraw, B.L.5
-
24
-
-
0032835795
-
Bradykinin-induced preconditioning in patients undergoing coronary angioplasty
-
Leesar, M.A., Stoddard, M.F., Manchikalapudi, S., and Bolli, R. (1999). Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 34, 639-650.
-
(1999)
J. Am. Coll. Cardiol.
, vol.34
, pp. 639-650
-
-
Leesar, M.A.1
Stoddard, M.F.2
Manchikalapudi, S.3
Bolli, R.4
-
25
-
-
77955373707
-
Cardioprotective properties of bradykinin: Role of the B2 receptor
-
Manolis, A.J., Marketou, M.E., Gavras, I., and Gavras, H. (2010). Cardioprotective properties of bradykinin: Role of the B2 receptor. Hypertens. Res. 33, 772-777.
-
(2010)
Hypertens. Res.
, vol.33
, pp. 772-777
-
-
Manolis, A.J.1
Marketou, M.E.2
Gavras, I.3
Gavras, H.4
-
26
-
-
0028989790
-
Kinin B1 receptors: A review
-
Marceau, F. (1995). Kinin B1 receptors: A review. Immunopharmacology 30, 1-26.
-
(1995)
Immunopharmacology
, vol.30
, pp. 1-26
-
-
Marceau, F.1
-
27
-
-
6444236841
-
Bradykinin receptor ligands: Therapeutic perspectives
-
Marceau, F. and Regoli, D. (2004). Bradykinin receptor ligands: Therapeutic perspectives. Nat. Rev. Drug Discov. 3, 845-852.
-
(2004)
Nat. Rev. Drug Discov.
, vol.3
, pp. 845-852
-
-
Marceau, F.1
Regoli, D.2
-
28
-
-
0031595552
-
The B1 receptors for kinins
-
Marceau, F., Hess, J.F., and Bachvarov, D.R. (1998). The B1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
-
(1998)
Pharmacol. Rev.
, vol.50
, pp. 357-386
-
-
Marceau, F.1
Hess, J.F.2
Bachvarov, D.R.3
-
29
-
-
77951136034
-
Cardioprotective effects of a selective B2 receptor agonist of bradykinin post-acute myocardial infarct
-
Marketou, M., Kintsurashvili, E., Papanicolaou, K.N., Lucero, H.A., Gavras, I., and Gavras, H. (2010). Cardioprotective effects of a selective B2 receptor agonist of bradykinin post-acute myocardial infarct. Am. J. Hypertens. 23, 562-568.
-
(2010)
Am. J. Hypertens.
, vol.23
, pp. 562-568
-
-
Marketou, M.1
Kintsurashvili, E.2
Papanicolaou, K.N.3
Lucero, H.A.4
Gavras, I.5
Gavras, H.6
-
30
-
-
0035031973
-
Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: Effects of angiotensin-converting enzyme inhibitors
-
Minai, K., Matsumoto, T., Horie, H., Ohira, N., Takashima, H., Yokohama, H., and Kinoshita, M. (2001). Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: Effects of angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 37, 1565-1570.
-
(2001)
J. Am. Coll. Cardiol.
, vol.37
, pp. 1565-1570
-
-
Minai, K.1
Matsumoto, T.2
Horie, H.3
Ohira, N.4
Takashima, H.5
Yokohama, H.6
Kinoshita, M.7
-
31
-
-
84876586522
-
-
In: The Kallikrein-Kinin System in Health and Disease. H. Fritz I. Schmidt, and G. Dietze, eds. (Munich, Germany: Limbach- Verlag Braunschweig)
-
M ü ller-Esterl, W. (1989). Kinininogen, kinins and kinships. In: The Kallikrein-Kinin System in Health and Disease. H. Fritz, I. Schmidt, and G. Dietze, eds. (Munich, Germany: Limbach-Verlag Braunschweig), pp. 289-300.
-
(1989)
Kinininogen, kinins and kinships
, pp. 289-300
-
-
Müller-Esterl, W.1
-
32
-
-
33747607036
-
Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans
-
Murphey, L.J., Malave, H.A., Petro, J., Biaggioni, I., Byrne, D.W., Vaughan, D.E., Luther, J.M., Pretorius, M., and Brown, N.J. (2006). Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. J. Pharmacol. Exp. Ther. 318, 1287-1292.
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.318
, pp. 1287-1292
-
-
Murphey, L.J.1
Malave, H.A.2
Petro, J.3
Biaggioni, I.4
Byrne, D.W.5
Vaughan, D.E.6
Luther, J.M.7
Pretorius, M.8
Brown, N.J.9
-
33
-
-
73149092309
-
A cysteine-type carboxypeptidase, cathepsin X, generates peptide receptor agonists
-
Nagler, D.K., Kraus, S., Feierler, J., Mentele, R., Lottspeich, F., Jochum, M., and Faussner, A. (2010). A cysteine-type carboxypeptidase, cathepsin X, generates peptide receptor agonists. Int. Immunopharmacol. 10, 134-139.
-
(2010)
Int. Immunopharmacol.
, vol.10
, pp. 134-139
-
-
Nagler, D.K.1
Kraus, S.2
Feierler, J.3
Mentele, R.4
Lottspeich, F.5
Jochum, M.6
Faussner, A.7
-
34
-
-
0036011344
-
Kinin B1 receptor antagonists with multienzymatic resistance properties
-
Neugebauer, W., Blais, P.A., Halle, S., Filteau, C., Regoli, D., and Gobeil, F. Jr. (2002). Kinin B1 receptor antagonists with multienzymatic resistance properties. Can. J. Physiol. Pharmacol. 80, 287-292.
-
(2002)
Can. J. Physiol. Pharmacol.
, vol.80
, pp. 287-292
-
-
Neugebauer, W.1
Blais, P.A.2
Halle, S.3
Filteau, C.4
Regoli, D.5
Gobeil Jr., F.6
-
35
-
-
0029414702
-
Kinin B1 and B2 receptors in the mouse
-
Nsa Allogho, S., Gobeil, F., Pheng, L.H., Nguyen-Le, X.K., Neugebauer, W., and Regoli, D. (1995). Kinin B1 and B2 receptors in the mouse. Can. J. Physiol. Pharmacol. 73, 1759-1764.
-
(1995)
Can. J. Physiol. Pharmacol.
, vol.73
, pp. 1759-1764
-
-
Nsa Allogho, S.1
Gobeil, F.2
Pheng, L.H.3
Nguyen-Le, X.K.4
Neugebauer, W.5
Regoli, D.6
-
36
-
-
0030610614
-
Antagonists for kinin B1 and B2 receptors in the mouse
-
Nsa Allogho, S., Gobeil, F., Pheng, L.H., Nguyen-Le, X.K., Neugebauer, W., and Regoli, D. (1997). Antagonists for kinin B1 and B2 receptors in the mouse. Can. J. Physiol. Pharmacol. 75, 558-562.
-
(1997)
Can. J. Physiol. Pharmacol.
, vol.75
, pp. 558-562
-
-
Nsa Allogho, S.1
Gobeil, F.2
Pheng, L.H.3
Nguyen-Le, X.K.4
Neugebauer, W.5
Regoli, D.6
-
37
-
-
0031935681
-
Effects of kinins on isolated stomachs of control and transgenic knockout B2 receptor mice
-
Nsa Allogho, S., Gobeil, F., Perron, S.I., Hess, J.F., and Regoli, D. (1998). Effects of kinins on isolated stomachs of control and transgenic knockout B2 receptor mice. Naunyn Schmiedebergs Arch. Pharmacol. 357, 191-196.
-
(1998)
Naunyn Schmiedebergs Arch. Pharmacol.
, vol.357
, pp. 191-196
-
-
Nsa Allogho, S.1
Gobeil, F.2
Perron, S.I.3
Hess, J.F.4
Regoli, D.5
-
38
-
-
0033101753
-
Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin
-
Prasad, A., Husain, S., and Quyyumi, A.A. (1999). Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: A potential role of bradykinin. J. Am. Coll. Cardiol. 33, 796-804.
-
(1999)
J. Am. Coll. Cardiol.
, vol.33
, pp. 796-804
-
-
Prasad, A.1
Husain, S.2
Quyyumi, A.A.3
-
39
-
-
0037417843
-
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin
-
Pretorius, M., Rosenbaum, D., Vaughan, D.E., and Brown, N.J. (2003). Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation 107, 579-585.
-
(2003)
Circulation
, vol.107
, pp. 579-585
-
-
Pretorius, M.1
Rosenbaum, D.2
Vaughan, D.E.3
Brown, N.J.4
-
40
-
-
0022516145
-
Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels
-
Regoli, D., Drapeau, G., Rovero, P., Dion, S., Rhaleb, N.E., Barabe, J., D'Orleans-Juste, P., and Ward, P. (1986). Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels. Eur. J. Pharmacol. 127, 219-224.
-
(1986)
Eur. J. Pharmacol.
, vol.127
, pp. 219-224
-
-
Regoli, D.1
Drapeau, G.2
Rovero, P.3
Dion, S.4
Rhaleb, N.E.5
Barabe, J.6
D'Orleans-Juste, P.7
Ward, P.8
-
41
-
-
0028102504
-
Bradykinin receptor types and B2 subtypes
-
Regoli, D., Gobeil, F., Nguyen, Q.T., Jukic, D., Seoane, P.R., Salvino, J.M., and Sawutz, D.G. (1994). Bradykinin receptor types and B2 subtypes. Life Sci. 55, 735-749.
-
(1994)
Life Sci.
, vol.55
, pp. 735-749
-
-
Regoli, D.1
Gobeil, F.2
Nguyen, Q.T.3
Jukic, D.4
Seoane, P.R.5
Salvino, J.M.6
Sawutz, D.G.7
-
42
-
-
0032077036
-
Bradykinin receptors and their antagonists
-
Regoli, D., Nsa Allogho, S., Rizzi, A., and Gobeil, F.J. (1998). Bradykinin receptors and their antagonists. Eur. J. Pharmacol. 348, 1-10.
-
(1998)
Eur. J. Pharmacol.
, vol.348
, pp. 1-10
-
-
Regoli, D.1
Nsa Allogho, S.2
Rizzi, A.3
Gobeil, F.J.4
-
43
-
-
0035109684
-
Classification of kinin receptors
-
Regoli, D., Rizzi, A., Perron, S.I., and Gobeil, F. Jr. (2001). Classification of kinin receptors. Biol. Chem. 382, 31-35.
-
(2001)
Biol. Chem.
, vol.382
, pp. 31-35
-
-
Regoli, D.1
Rizzi, A.2
Perron, S.I.3
Gobeil Jr., F.4
-
44
-
-
84861341974
-
Impact of kinins in the treatment of cardiovascular diseases
-
Regoli, D., Plante, G.E., and Gobeil, F. Jr. (2012). Impact of kinins in the treatment of cardiovascular diseases. Pharmacol. Ther. 135, 94-111.
-
(2012)
Pharmacol. Ther.
, vol.135
, pp. 94-111
-
-
Regoli, D.1
Plante, G.E.2
Gobeil Jr., F.3
-
45
-
-
0025128469
-
Structure-activity studies on bradykinin and related peptides: Agonists
-
Rhaleb, N.E., Drapeau, G., Dion, S., Jukic, D., Rouissi, N., and Regoli, D. (1990). Structure-activity studies on bradykinin and related peptides: Agonists. Br. J. Pharmacol. 99, 445-448.
-
(1990)
Br. J. Pharmacol.
, vol.99
, pp. 445-448
-
-
Rhaleb, N.E.1
Drapeau, G.2
Dion, S.3
Jukic, D.4
Rouissi, N.5
Regoli, D.6
-
46
-
-
33745591921
-
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin
-
Shariat-Madar, Z., Mahdi, F., Warnock, M., Homeister, J.W., Srikanth, S., Krijanovski, Y., Murphey, L.J., Jaffa, A.A., and Schmaier, A.H. (2006). Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood 108, 192-199.
-
(2006)
Blood
, vol.108
, pp. 192-199
-
-
Shariat-Madar, Z.1
Mahdi, F.2
Warnock, M.3
Homeister, J.W.4
Srikanth, S.5
Krijanovski, Y.6
Murphey, L.J.7
Jaffa, A.A.8
Schmaier, A.H.9
-
47
-
-
0031886603
-
Cellular carboxypeptidases
-
Skidgel, R.A. and Erdos, E.G. (1998). Cellular carboxypeptidases. Immunol. Rev. 161, 129-141.
-
(1998)
Immunol. Rev.
, vol.161
, pp. 129-141
-
-
Skidgel, R.A.1
Erdos, E.G.2
-
49
-
-
33748533791
-
Kinins and cardiovascular diseases
-
Su, J.B. (2006). Kinins and cardiovascular diseases. Curr. Pharm. Des. 12, 3423-3435.
-
(2006)
Curr. Pharm. Des.
, vol.12
, pp. 3423-3435
-
-
Su, J.B.1
-
50
-
-
17844380295
-
Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by bradykinin
-
Tarutani, Y., Matsumoto, T., Takashima, H., Yamane, T., and Horie, M. (2005). Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by bradykinin. Hypertens. Res. 28, 59-66.
-
(2005)
Hypertens. Res.
, vol.28
, pp. 59-66
-
-
Tarutani, Y.1
Matsumoto, T.2
Takashima, H.3
Yamane, T.4
Horie, M.5
-
51
-
-
3242780767
-
Bradykinin preconditioning in coronary artery bypass grafting
-
Wei, M., Wang, X., Kuukasjarvi, P., Laurikka, J., Rinne, T., Honkonen, E.L., and Tarkka, M. (2004). Bradykinin preconditioning in coronary artery bypass grafting. Ann. Thorac. Surg. 78, 492-497.
-
(2004)
Ann. Thorac. Surg.
, vol.78
, pp. 492-497
-
-
Wei, M.1
Wang, X.2
Kuukasjarvi, P.3
Laurikka, J.4
Rinne, T.5
Honkonen, E.L.6
Tarkka, M.7
-
52
-
-
20244363204
-
Hoe 140 a new potent and long acting bradykininantagonist: In vivo studies
-
Wirth, K., Hock, F.J., Albus, U., Linz, W., Alpermann, H.G., Anagnostopoulos, H., Henk, S., Breipohl, G., Konig, W., Knolle, J., et al. (1991). Hoe 140 a new potent and long acting bradykininantagonist: In vivo studies. Br. J. Pharmacol. 102, 774-777.
-
(1991)
Br. J. Pharmacol.
, vol.102
, pp. 774-777
-
-
Wirth, K.1
Hock, F.J.2
Albus, U.3
Linz, W.4
Alpermann, H.G.5
Anagnostopoulos, H.6
Henk, S.7
Breipohl, G.8
Konig, W.9
Knolle, J.10
-
53
-
-
0031172655
-
Kinins and cardioprotection
-
Wirth, K.J., Linz, W., Wiemer, G., and Scholkens, B.A. (1997). Kinins and cardioprotection. Pharmacol. Res. 35, 527-530.
-
(1997)
Pharmacol. Res.
, vol.35
, pp. 527-530
-
-
Wirth, K.J.1
Linz, W.2
Wiemer, G.3
Scholkens, B.A.4
|